Evidence map›Paper›PMID 36897403›Full record

ReviewEuropean journal of pediatrics2023

Clinical practice - latest insights in optimizing the care of children with Down syndrome.

Helma B M van Gameren-Oosterom, Michel E Weijerman, Hester van Wieringen, J Peter de Winter, Anne-Marie van Wermeskerken

Abstract readReview
PubMed Publisher
In one paragraph

Review in European journal of pediatrics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Helma B M van Gameren-OosteromDepartment of Pediatrics, Groene Hart Ziekenhuis, P.O. Box 1098, 2800 BB, Gouda, The Netherlands. helma.gameren@ghz.nl.
Michel E WeijermanDepartment of Pediatrics, Alrijne, Leiderdorp, The Netherlands.
Hester van WieringenDepartment of Pediatrics, St. Antonius, Utrecht, The Netherlands.
J Peter de WinterDepartment of Pediatrics, Spaarne Gasthuis, Haarlem/Hoofddorp, The Netherlands.
Anne-Marie van WermeskerkenDepartment of Pediatrics, Flevoziekenhuis, Almere, The Netherlands.

Funding

Stichting Kwaliteitsgelden Medisch Specialisten 53043661
6 · The paper itself

Abstract

An essential part of the care of children with Down syndrome is secondary screening for comorbidity. It is well known that comorbidity frequently occurs in these children. A new update of the Dutch Down syndrome medical guideline was developed to create a sound evidence base for several of these conditions. We present the latest insights and recommendations from this Dutch medical guideline which are based on the most relevant literature currently available and developed with rigorous methodology. The main focus of this revision of the guideline was on obstructive sleep apnea and other airway problems and hematologic disorders, such as transient abnormal myelopoiesis, leukemia, and thyroid disorders. Conclusion: This is a short summary of the latest insights and recommendations from the updated Dutch medical guideline for children with Down syndrome.

Indexed as

Down SyndromeSleep Apnea, ObstructiveChildComorbidityHumansCareChildrenCongenital abnormalitiesDown syndromeGuidelineTrisomy 21

Identifiers

PMID36897403

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.